echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Active Ingredient Products News > The Synthetic Routes of Clebopride

    The Synthetic Routes of Clebopride

    • Last Update: 2023-05-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Clebopride is a synthetic compound that is commonly used in the pharmaceutical industry as a treatment for a range of medical conditions, including schizophrenia and bipolar disorder.
    The synthesis of Clebopride involves a number of steps and can be achieved through several different synthetic routes.


    The first synthetic route for Clebopride involves the conversion of piperidine-4-carboxylic acid to N-(4-chlorophenyl)isoxazole-5-carboxamide using a sequence of chemical reactions.
    This synthetic route begins by treating piperidine-4-carboxylic acid with chloroform and a base, such as sodium hydroxide, to form N-(4-chlorophenyl)isoxazole.
    The isoxazole is then treated with a carboxamide-forming reagent, such as dicyclohexylcarbodiimide (DCC) and hydroxybenzotriazole (HOBT), to form N-(4-chlorophenyl)isoxazole-5-carboxamide.


    Another synthetic route for Clebopride involves the conversion of 4-chloro-2,3-dimethoxy benzaldehyde to N-(4-chlorophenyl)isoxazole-5-carboxamide using a sequence of chemical reactions.
    This synthetic route begins by treating 4-chloro-2,3-dimethoxy benzaldehyde with an amine, such as secondary amines like piperidine or morpholine, to form a benzamide.
    The benzamide is then treated with an isocyanate, such as phosgene or carbonyldiimidazole, to form N-(4-chlorophenyl)isoxazole.
    The isoxazole is then treated with a carboxamide-forming reagent, such as DCC and HOBT, to form N-(4-chlorophenyl)isoxazole-5-carboxamide.


    Both of these synthetic routes involve the use of several different chemical reagents and can be complex and time-consuming.
    In addition, these routes involve the use of potentially hazardous reagents, such as phosgene, which must be handled with care to avoid accidents or injuries.


    A more recent synthetic route for Clebopride involves the use of a novel synthetic strategy known as "click chemistry.
    " This approach involves the use of a combination of metal complexes and organic compounds to form the desired product in a single, simple reaction step.
    This approach has the advantage of avoiding the use of potentially hazardous reagents and can be more efficient and cost-effective than traditional synthetic routes.


    In conclusion, Clebopride can be synthesized through several different routes, each with its own advantages and disadvantages.
    The choice of synthetic route will depend on a variety of factors, including the availability and cost of the starting materials, the desired yield and purity of the final product, and the safety and efficiency of the synthetic strategy.
    Regardless of the synthetic route chosen, Clebopride remains an important pharmaceutical compound with a wide range of therapeutic applications.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.